Jenica N Upshaw1, Marvin A Konstam2, David van Klaveren2, Farzad Noubary2, Gordon S Huggins2, David M Kent2. 1. From The CardioVascular Center (J.N.U., M.A.K., G.S.H.) and The Institute for Clinical Research and Health Policy Studies (D.v.K., F.N., D.M.K.), Tufts Medical Center, Boston, MA; and The Department of Public Health, Erasmus MC, University Medical Center Rotterdam, The Netherlands (D.v.K.). jupshaw@tuftsmedicalcenter.org. 2. From The CardioVascular Center (J.N.U., M.A.K., G.S.H.) and The Institute for Clinical Research and Health Policy Studies (D.v.K., F.N., D.M.K.), Tufts Medical Center, Boston, MA; and The Department of Public Health, Erasmus MC, University Medical Center Rotterdam, The Netherlands (D.v.K.).
Abstract
BACKGROUND:Outpatients with heart failure (HF) who are at high risk for HF hospitalization and death may benefit from early identification. We sought to develop and externally validate a model to predict both HF hospitalization and mortality that accounts for the semicompeting nature of the 2 outcomes and captures the risk associated with the transition from the stable outpatient state to the post-HF hospitalization state. METHODS AND RESULTS: A multistate model to predict HF hospitalization and all-cause mortality was derived using data (n=3834) from the HEAAL study (Heart Failure Endpoint evaluation of Angiotensin II Antagonist Losartan), a multinational randomized trial in symptomatic patients with reduced left ventricular ejection fraction. Twelve easily and reliably obtainable demographic and clinical predictors were prespecified for model inclusion. Model performance was assessed in the SCD-HeFT cohort (Sudden Cardiac Death in Heart Failure Trial; n=2521). At 1 year, the probability of being alive without HF hospitalization was 94% for a typical patient in the lowest risk quintile and 77% for a typical patient in the highest risk quintile and this variability in risk continued through 7 years of follow-up. The model c-index was 0.72 in the derivation cohort, 0.66 in the validation cohort, and 0.69 in the implantable cardiac defibrillator arm of the validation cohort. There was excellent calibration across quintiles of predicted risk. CONCLUSIONS: Our findings illustrate the advantages of a multistate modeling approach, providing estimates of HF hospitalization and death in the same model, comparison of predictors for the different outcomes and demonstrating the different trajectories of patients based on baseline characteristics and intermediary events. CLINICAL TRIAL REGISTRATION: URL: http://www.clinicaltrials.gov. Unique identifiers: NCT00000609 and NCT00090259.
RCT Entities:
BACKGROUND: Outpatients with heart failure (HF) who are at high risk for HF hospitalization and death may benefit from early identification. We sought to develop and externally validate a model to predict both HF hospitalization and mortality that accounts for the semicompeting nature of the 2 outcomes and captures the risk associated with the transition from the stable outpatient state to the post-HF hospitalization state. METHODS AND RESULTS: A multistate model to predict HF hospitalization and all-cause mortality was derived using data (n=3834) from the HEAAL study (Heart Failure Endpoint evaluation of Angiotensin II Antagonist Losartan), a multinational randomized trial in symptomatic patients with reduced left ventricular ejection fraction. Twelve easily and reliably obtainable demographic and clinical predictors were prespecified for model inclusion. Model performance was assessed in the SCD-HeFT cohort (Sudden Cardiac Death in Heart Failure Trial; n=2521). At 1 year, the probability of being alive without HF hospitalization was 94% for a typical patient in the lowest risk quintile and 77% for a typical patient in the highest risk quintile and this variability in risk continued through 7 years of follow-up. The model c-index was 0.72 in the derivation cohort, 0.66 in the validation cohort, and 0.69 in the implantable cardiac defibrillator arm of the validation cohort. There was excellent calibration across quintiles of predicted risk. CONCLUSIONS: Our findings illustrate the advantages of a multistate modeling approach, providing estimates of HF hospitalization and death in the same model, comparison of predictors for the different outcomes and demonstrating the different trajectories of patients based on baseline characteristics and intermediary events. CLINICAL TRIAL REGISTRATION: URL: http://www.clinicaltrials.gov. Unique identifiers: NCT00000609 and NCT00090259.
Authors: Gust H Bardy; Kerry L Lee; Daniel B Mark; Jeanne E Poole; Douglas L Packer; Robin Boineau; Michael Domanski; Charles Troutman; Jill Anderson; George Johnson; Steven E McNulty; Nancy Clapp-Channing; Linda D Davidson-Ray; Elizabeth S Fraulo; Daniel P Fishbein; Richard M Luceri; John H Ip Journal: N Engl J Med Date: 2005-01-20 Impact factor: 91.245
Authors: Ana C Alba; Thomas Agoritsas; Milosz Jankowski; Delphine Courvoisier; Stephen D Walter; Gordon H Guyatt; Heather J Ross Journal: Circ Heart Fail Date: 2013-07-25 Impact factor: 8.790
Authors: Michel Komajda; Peter E Carson; Scott Hetzel; Robert McKelvie; John McMurray; Agata Ptaszynska; Michael R Zile; David Demets; Barry M Massie Journal: Circ Heart Fail Date: 2010-11-10 Impact factor: 8.790
Authors: Benjamin K Johnson; Ross F Garberich; Timothy D Henry; William T Katsiyiannis; Jay Sengupta; Ankur Kalra; Robert G Hauser; Meghan E Lardy; Marc C Newell Journal: Heart Rhythm Date: 2015-10-13 Impact factor: 6.343
Authors: Wayne C Levy; Dariush Mozaffarian; David T Linker; Santosh C Sutradhar; Stefan D Anker; Anne B Cropp; Inder Anand; Aldo Maggioni; Paul Burton; Mark D Sullivan; Bertram Pitt; Philip A Poole-Wilson; Douglas L Mann; Milton Packer Journal: Circulation Date: 2006-03-13 Impact factor: 29.690
Authors: F Leyva; P W X Foley; B Stegemann; J A Ward; L L Ng; M P Frenneaux; F Regoli; R E A Smith; A Auricchio Journal: Heart Date: 2009-07-09 Impact factor: 5.994
Authors: Marvin A Konstam; Philip A Poole-Wilson; Kenneth Dickstein; Helmut Drexler; Steven J Justice; Michel Komajda; William Malbecq; Felipe A Martinez; James D Neaton; Gunter A J Riegger; Soneil Guptha Journal: Eur J Heart Fail Date: 2008-09-02 Impact factor: 15.534
Authors: Marvin A Konstam; James D Neaton; Kenneth Dickstein; Helmut Drexler; Michel Komajda; Felipe A Martinez; Gunter A J Riegger; William Malbecq; Ronald D Smith; Soneil Guptha; Philip A Poole-Wilson Journal: Lancet Date: 2009-11-16 Impact factor: 79.321
Authors: Meaghan Lunney; Marinella Ruospo; Patrizia Natale; Robert R Quinn; Paul E Ronksley; Ioannis Konstantinidis; Suetonia C Palmer; Marcello Tonelli; Giovanni Fm Strippoli; Pietro Ravani Journal: Cochrane Database Syst Rev Date: 2020-02-27
Authors: Michael M Hammond; Changyu Shen; Stephanie Li; Dhruv S Kazi; Marwa A Sabe; A Reshad Garan; Lawrence J Markson; Warren J Manning; Allan L Klein; Sherif F Nagueh; Jordan B Strom Journal: PLoS One Date: 2020-12-22 Impact factor: 3.240
Authors: Johannes T Neumann; Le T P Thao; Emily Callander; Prudence R Carr; Vazhma Qaderi; Mark R Nelson; Christopher M Reid; Robyn L Woods; Suzanne G Orchard; Rory Wolfe; Galina Polekhina; Jeff D Williamson; James M Trauer; Anne B Newman; Anne M Murray; Michael E Ernst; Andrew M Tonkin; John J McNeil Journal: Lancet Healthy Longev Date: 2022-02-07
Authors: Alexandros Rekkas; Jessica K Paulus; Gowri Raman; John B Wong; Ewout W Steyerberg; Peter R Rijnbeek; David M Kent; David van Klaveren Journal: BMC Med Res Methodol Date: 2020-10-23 Impact factor: 4.615